Arama Sonuçları - "Checkmat"

Single-Cell Analysis Identifies Distinct Populations of Cytotoxic CD4+ T Cells Linked to the Therapeutic Efficacy of Immune Checkpoint Inhibitors in Metastatic Renal Cell Carcinoma Yazar: Yang X, Wu J, Fan L, Chen B, Zhang S, Zheng W

Connect to this object online.

Contemporary treatment of metastatic renal cell carcinoma Yazar: Igor Stukalin, Nimira Alimohamed, Daniel Y.C. Heng

Connect to this object online.

Drivers of audit failure and fraudulent financial reporting: evidence from Nigerian distressed banks / Augustine Ehijeagbon Akhidime Yazar: Akhidime, Augustine Ehijeagbon

Link Metadata

Custeio de eventos adversos resultantes do tratamento de pacientes com câncer de cabeça e pescoço recorrente ou metastático que progrediram durante ou em até 6 meses após tratament... Yazar: Giselle Vaz Costa, Ana Paula Casagrande Drozda Oliveira, Paola de Souza Marinheiro, Graziela Dalla Rosa Bernardino

Connect to this object online.

PD-1/PD-L1 Inhibitors in Cervical Cancer Yazar: Yuncong Liu, Yuncong Liu, Li Wu, Ruizhan Tong, Feiyue Yang, Limei Yin, Limei Yin, Mengqian Li, Mengqian Li, Liting You, Liting You, Jianxin Xue, Jianxin Xue, You Lu, You Lu

Connect to this object online.

Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab for Advanced Non-Small-Cell Lung Cancer Yazar: Xiaomin Wan, Xiaohui Zeng, Liubao Peng, Ye Peng, Qiao Liu, Lidan Yi, Xia Luo, Qijian Deng, Qijian Deng, Chongqing Tan

Connect to this object online.

Cost-Utility Analysis of Nivolumab in Adjuvant Treatment of Melanoma in France Yazar: Bruno Bregman, Siguroli Teitsson, Isabella Orsini, François-Emery Cotté, Adenike Amadi, Andriy Moshyk, Stéphane Roze, Anne-Françoise Gaudin

Connect to this object online.

Cost-Effectiveness of Nivolumab Plus Ipilimumab as First-Line Therapy in Advanced Non-small-cell Lung Cancer Yazar: Xuezhi Hao, Aizong Shen, Bin Wu

Connect to this object online.

Economic evaluation of adverse events of dabrafenib plus trametinib versus nivolumab in patients with advanced BRAF-mutant cutaneous melanoma for adjuvant therapy in Germany Yazar: S Wahler, A Müller, C Koll, P Seyed-Abbaszadeh, JM Von Der Schulenburg

Connect to this object online.

Interpretation of PD-L1 expression in gastric cancer: summary of a consensus meeting of Korean gastrointestinal pathologists Yazar: Soomin Ahn, Yoonjin Kwak, Gui Young Kwon, Kyoung-Mee Kim, Moonsik Kim, Hyunki Kim, Young Soo Park, Hyeon Jeong Oh, Kyoungyul Lee, Sung Hak Lee, Hye Seung Lee

Connect to this object online.

Targeted literature review on use of tumor mutational burden status and programmed cell death ligand 1 expression to predict outcomes of checkpoint inhibitor treatment Yazar: Tina Krieger, Isobel Pearson, Judith Bell, Jim Doherty, Paul Robbins

Connect to this object online.

Nivolumab Versus Sorafenib as First-Line Therapy for Advanced Hepatocellular Carcinoma: A Cost-Effectiveness Analysis Yazar: Yan Li, Xueyan Liang, Huijuan Li, Tong Yang, Sitong Guo, Xiaoyu Chen

Connect to this object online.

Cost-effectiveness comparison of cabozantinib with everolimus, axitinib, and nivolumab in the treatment of advanced renal cell carcinoma following the failure of prior therapy in... Yazar: Meng J, Lister J, Vataire AL, Casciano R, Dinet J

Connect to this object online.

ANALISIS VERBA IRERU, KOMERU DAN TSUMERU SEBAGAI POLISEMI Yazar: Danial Yuanda Saputra, -

Link Metadata